Related Experiment Video
Updated: Jul 15, 2026

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse
Published on: May 31, 2016
5-HT3 receptor antagonists ameliorate fatigue: so much potential, so little knowledge!
1Cellular and Molecular Neuropharmacology Research Group, Department of Pharmacology, Division of Neuroscience, The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. n.m.barnes@bham.ac.uk
5-HT3 receptor blockade shows promise for treating fatigue. Targeting the serotonin system may offer new therapeutic strategies for this common symptom.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Fatigue is a widespread and clinically significant symptom.
- Growing evidence suggests a role for the 5-HT3 receptor system in fatigue.
Discussion:
- 5-HT3 receptor blockade may alleviate fatigue.
- Understanding the underlying mechanisms is crucial for developing effective treatments.
Key Insights:
- Targeting the 5-HT3 receptor system presents a potential therapeutic avenue for fatigue.
- Further research is warranted to elucidate the precise mechanisms.
Outlook:
- Future therapies for fatigue may involve modulating the 5-HT system.
- Investigating the neurobiological underpinnings of fatigue is essential.
Related Concept Videos
Muscle Recovery and Fatigue
Antidepressant Drugs: MAOIs and Other Agents
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Fatigue

